PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32885412-5	2021	Rimonabant alone stimulates protein synthesis in a time- and dose-dependent manner through mTOR- and intracellular calcium-dependent mechanisms.	Rimonabant	0-10	mechanistic target of rapamycin kinase	Homo sapiens	91-95	
24303008-6	2013	This anorexigenic effect is likely a consequence of decreases in gastric ghrelin secretion induced by the activation of the mTOR/S6K1 intracellular pathway in the stomach following treatment with rimonabant.	Rimonabant	196-206	mechanistic target of rapamycin kinase	Homo sapiens	124-128	
24671870-6	2014	Other promising strategies are inhibition of interleukin 1beta signaling by drugs such as VX-765; modulation of sphingosine 1-phosphate signaling by drugs such as fingolimod; activation of the mammalian target of rapamycin by drugs such as rapamycin; the hormone erythropoietin; and, paradoxically, drugs such as the alpha2 adrenergic receptor antagonist atipamezole and the CB1 cannabinoid antagonist SR141716A (rimonabant) with proexcitatory activity.	Rimonabant	402-411	mechanistic target of rapamycin kinase	Homo sapiens	193-222	
24671870-6	2014	Other promising strategies are inhibition of interleukin 1beta signaling by drugs such as VX-765; modulation of sphingosine 1-phosphate signaling by drugs such as fingolimod; activation of the mammalian target of rapamycin by drugs such as rapamycin; the hormone erythropoietin; and, paradoxically, drugs such as the alpha2 adrenergic receptor antagonist atipamezole and the CB1 cannabinoid antagonist SR141716A (rimonabant) with proexcitatory activity.	Rimonabant	413-423	mechanistic target of rapamycin kinase	Homo sapiens	193-222